U-Blot® Research Grade EmapalumabCat. No. WA2776$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade EmapalumabCat. No. WA2776
U-Blot® Research Grade EmactuzumabCat. No. WA2775
U-Blot® Research Grade EluvixtamabCat. No. WA2774
U-Blot® Research Grade EltrekibartCat. No. WA2773
U-Blot® Research Grade eltivutabartCat. No. WA2772
U-Blot® Research Grade ElsilimomabCat. No. WA2771
U-Blot® Research Grade ElriterceptCat. No. WA2770
U-Blot® Research Grade ElranatamabCat. No. WA2769
U-Blot® Research Grade ElotuzumabCat. No. WA2768
U-Blot® Research Grade eliroptamigCat. No. WA2767
U-Blot® Research Grade elipunerceptCat. No. WA2766
U-Blot® Research Grade ElipovimabCat. No. WA2765